Epic Sciences Inc. raised $40 million in a series D round, proving investors still have strong interest in the 9-year-old liquid biopsy specialist. The San Diego-based company has taken in about $85 million since it spun out of the Scripps Research Institute in 2008. Its most recent round was led by Hermed Capital. Altos Capital Partners, Domain Associates, Genomic Health Inc., Pagoda Investment, Reach Tone Ltd., RMI Partners, Sabby Capital and VI Ventures also participated in the series D financing.